Healthcare Why vital drugs are turning costlier Updated : December 16, 2019 12:49 PM IST The latest price increase was based on a recommendation by the Standing Committee on Affordable Medicines and Health Products under Niti Aayog. While the price rise came as a bitter pill to swallow, many in the industry who were sounding warning bells over the country’s growing dependence on imported Chinese bulk drugs, are not surprised. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.